Previous reports have shown that serum levels of inflammatory proteins, such as TNF-α, IL-16, soluble TNF receptors (sTNFR1 and 2) were increased in the serum of T1D patients with micro-vascular (23–25) and macro-vascular complications (26). This evidence concerns the gene TNF and type 1 diabetes mellitus.